OM

2.8302.75%
RM

Renee M. Gaeta

Independent Director

Ms. Renee M. Gaeta is CFO, Principal Financial Officer & Principal Accounting Officer of Outset Medical, Inc. from June 3, 2025. She served as Chief Financial Officer of Shockwave Medical, Inc. since February 05, 2024 until May 31, 2024. She serves as Chief Financial Officer at Eko Devices, Inc. since 2021. From July 2021 to January 2024, Ms. Gaeta served as the Chief Financial Officer of Eko Health, Inc. She serves as Independent Director of Candel Therapeutics, Inc. since August 08, 2022. She served as Independent Director of SeaSpine Holdings Corporation from February 19, 2019 to January 2023. She served as Chief Financial Officer and a Member of The Executive Team at Establishment Labs Holdings Inc. since July 2017 until July 30, 2021. She joined Establishment Labs in 2017. Ms. Gaeta had been the Chief Financial Officer at Establishment Labs S.A. since July 12, 2017 until July 30, 2021. Ms. Gaeta has more than a decade of financial leadership experience to Establishment Labs. She served as Vice President and Corporate Controller at Sientra, Inc. from August 2014 to June 2017. At Sientra, she served as a Member of The Executive Team and Headed the finance department. She was instrumental in preparing company during its pre-IPO stage establishing compliant systems and controls and played a key role in Sientra's successful Initial Public Offering (IPO) and Follow-On Offering. Prior to Sientra, from 2004 to 2014, Ms. Gaeta spent with KPMG, LLP, rising through organization to the role of Director of Transaction & Restructuring. In this capacity, she managed multiple global clients and specialized in complex transaction and restructuring deals with a focus on evaluation and application of technical accounting. She served as an Advisory Director in the Transactions and Restructuring Group. Ms. Gaeta holds a Bachelor of Science in Accounting from Loyola Marymount University and is a Certified Public Accountant in the State of California.

Positions